Novel retinoblastoma mutation abrogating the interaction to E2F2/3, but not E2F1, led to selective suppression of thyroid tumors

Hideaki Toki, Maki Inoue, Osamu Minowa, Hiromi Motegi, Yuriko Saiki, Shigeharu Wakana, Hiroshi Masuya, Yoichi Gondo, Toshihiko Shiroishi, Ryoji Yao, Tetsuo Noda

Research output: Contribution to journalArticlepeer-review

6 Citations (Scopus)


Mutant mouse models are indispensable tools for clarifying gene functions and elucidating the pathogenic mechanisms of human diseases. Here, we describe novel cancer models bearing point mutations in the retinoblastoma gene (Rb1) generated by N-ethyl-N-nitrosourea mutagenesis. Two mutations in splice sites reduced Rb1 expression and led to a tumor spectrum and incidence similar to those observed in the conventional Rb1 knockout mice. The missense mutant, Rb1D326V/+, developed pituitary tumors, but thyroid tumors were completely suppressed. Immunohistochemical analyses of thyroid tissue revealed that E2F1, but not E2F2/3, was selectively inactivated, indicating that the mutant Rb protein (pRb) suppressed thyroid tumors by inactivating E2F1. Interestingly, Rb1D326V/+ mice developed pituitary tumors that originated from the intermediate lobe of the pituitary, despite selective inactivation of E2F1. Furthermore, in the anterior lobe of the pituitary, other E2F were also inactivated. These observations show that pRb mediates the inactivation of E2F function and its contribution to tumorigenesis is highly dependent on the cell type. Last, by using a reconstitution assay of synthesized proteins, we showed that the D326V missense pRb bound to E2F1 but failed to interact with E2F2/3. These results reveal the effect of the pRb N-terminal domain on E2F function and the impact of the protein on tumorigenesis. Thus, this mutant mouse model can be used to investigate human Rb family-bearing mutations at the N-terminal region. We generated three novel cancer model mice by ENU mutagenesis, which harbor novel point mutations in the Rb1 gene: two splice-site mutations and one missense mutation. Heterozygous animals of the splice-site mutations developed pituitary and thyroid tumors, similarly to Rb1+/- mice. In contrast, the heterozygous missense mutants developed only pituitary tumors, thus rendering these mutant mice useful tools to investigate the cell- or tissue-specific tumor suppressive mechanism of pRb.

Original languageEnglish
Pages (from-to)1360-1368
Number of pages9
JournalCancer Science
Issue number10
Publication statusPublished - 2014 Oct 1


  • E2F transcription factors
  • Endocrine tumors
  • Mice
  • Mutagenesis
  • Retinoblastoma


Dive into the research topics of 'Novel retinoblastoma mutation abrogating the interaction to E2F2/3, but not E2F1, led to selective suppression of thyroid tumors'. Together they form a unique fingerprint.

Cite this